Frequently Asked Questions
The market is segmented based on Global Cardiac Markers Rapid Tests and Point of Care (POC) Market, By Type (Troponin Rapid Tests and Point of Care Testing, Brain Natriuretic Peptide (BNP) Rapid Tests and Point of Care Testing, Other Cardiac Markers Rapid Tests and Point of Care Testing), Product (Reagents, Instruments), Testing (Lab, Point of Care), End-Users (Professional Diagnostic Centers, Hospitals/Critical Care Centers, Home Care Settings, Research Laboratories, Others) – Industry Trends and Forecast to 2030.
.
The Global Cardiac Markers Rapid Tests And Point Of Care Market size was valued at USD 13.00 USD Billion in 2022.
The Global Cardiac Markers Rapid Tests And Point Of Care Market is projected to grow at a CAGR of 13.6% during the forecast period of 2023 to 2030.
The major players operating in the market include Abbott, Hoffmann, La Roche, Siemens Healthcare Private Limited, Beckman Coulter, BD, Johnson & Johnson Services, Instrumentation Laboratory, PTS Diagnostics, Abaxis, Medtronic, Opti Medical, Sienco, Alpha Scientific Electronics, AccuBioTech Co., ACON Laboratories, bioMérieux, Ortho Clinical Diagnostics, Randox Laboratories .
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of the Middle East and Africa.
